"Prevention and Control of Tuberculosis in Correctional Institutions:" Recommendations, Advisory Committee for Elimination of Tuberculosis

Important note: Information in this article was accurate in 1989. The state of the art may have changed since the publication date.

"Prevention and Control of Tuberculosis in Correctional Institutions:" Recommendations, Advisory Committee for Elimination of Tuberculosis

Journal of the American Medical Association (12/15/89) Vol. 262, No. 23, P. 3258

Abstract: HIV infection is among the factors heightening the need for correctional institutions to take precautions against outbreaks of tuberculosis (TB), according to the Advisory Committee for the Elimination of Tuberculosis. The rate of HIV infection in state/federal prisons is an estimated 75 per 100,000, compared to 13 per 100,000 in the general population. In several areas of the country, the high rate of HIV infection has contributed to TB rates in prisons that are several times higher than those of the general population. The committee recommends that each institution designate an official to operate a TB prevention and control program. Surveillance, containment, and assessment should be the goals of the TB program. Institutions should identify and report all TB cases, and begin appropriate therapy. To contain TB outbreaks, prisons need appropriate diagnostic, treatment, prevention, and laboratory services. In assessing programs, officials need to determine whether they are effectively carrying out surveillance and containment plans.

891215
AD890004

Copyright © 1989 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 1989. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1989. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.